Nexpoint Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-768,251
Closed -$20.8M 102
2024
Q2
$20.8M Buy
+768,251
New +$16M 2.7% 12
2021
Q2
Sell
-10,000
Closed -$507K 203
2021
Q1
$507K Hold
10,000
0.13% 88
2020
Q4
$630K Hold
10,000
0.21% 91
2020
Q3
$672K Hold
10,000
0.15% 94
2020
Q2
$419K Hold
10,000
0.09% 131
2020
Q1
$315K Hold
10,000
0.06% 157
2019
Q4
$404K Hold
10,000
0.03% 215
2019
Q3
$325K Buy
+10,000
New +$398K 0.02% 280

Other funds holding SILK

Nexpoint Asset Management's SILK Position: Q3 2024 in Review

Nexpoint Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 768,251 shares — an estimated $20.8M sold.

Nexpoint Asset Management first reported a position in SILK in Q3 2019 and held it in 8 quarters. The position peaked at $20.8M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Nexpoint Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Nexpoint Asset Management sold 768,251 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $20.8M.
  • Nexpoint Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Nexpoint Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $20.8M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Nexpoint Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.